Apeloa Pharma plans share repurchase of up to CNY 150m

Apeloa Pharmaceutical (SZSE:000739) announced a plan to repurchase company shares using its own funds, with a total amount ranging from ¥75 million to ¥150 million. The repurchased shares will be used for equity incentives or employee stock ownership plans, and any unused shares after 36 months will be canceled following due procedures. The repurchase price will not exceed ¥22 per share. The repurchase period will be within 12 months from the date the board approves the plan. The company believes this buyback will not significantly impact its operations, finances, or future development. Apeloa's management also confirmed no insider trading or market manipulation occurred prior to the announcement.